Form 4 for SLDB Solid Biosciences Inc.
Accepted 2025-07-08 00:00:00 ET · period of report 2025-07-06 · accession 0000950170-25-094690 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-07-08 | 2025-07-06 | SLDB | SMITH IAN F | Dir | M - OptEx | — | +4,573 | 122.1K | +4% | — |
| D | 2025-07-08 | 2025-07-06 | SLDB | SMITH IAN F | Dir | M - OptEx | $0.00 | -4,573 | 9,146 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-06 | M | A | 4,573 | — | 122,119 | D | — | — | (F1) Restricted stock units convert to common stock on a one-for-one basis. |
| 2 | Derivative | Restricted Stock Units | 2025-07-06 | M | D | 4,573 | $0.00 | 9,146 | D | — · — to — | 4,573 Common Stock | (F1) Restricted stock units convert to common stock on a one-for-one basis. (F2) The restricted stock units were granted on January 6, 2025 (the "Grant Date") and vest in equal quarterly installments beginning three months from the Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of the early termination of the Third Amendment to Executive Chair Agreement between the Issuer and the reporting person (the "Smith Agreement") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full. |